Sanna Bastiano (CIK 0001829069)

Latest company ownership

VRTX - VERTEX PHARMACEUTICALS INC / MA
Role: EVP, Cell & Genetic Therapies
Shares held
32,038
Last filed at
May 9, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 5, 2023 May 9, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 23.8 -3,272 -9.27% ✓ $1.1M
May 2, 2023 May 4, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 20.0 -4,403 -11.09% ✓ $1.5M
Apr 12, 2023 Apr 14, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 15.0 -7,567 -16.00% ✓ $2.5M
Apr 4, 2023 Apr 6, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 45.0 -522 -1.09% ✓ $164.9K
Mar 31, 2023 Apr 4, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 20.0 -1,466 -2.98% ✗ $459.9K
Mar 16, 2023 Mar 20, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 30.0 -2,746 -5.28% ✓ $825.4K
Feb 24, 2023 Feb 28, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 17.5 -3,970 -7.09% ✗ $1.1M
Feb 17, 2023 Feb 22, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 17.5 -3,750 -6.28% ✗ $1.1M
Feb 14, 2023 Feb 16, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 35.0 -2,181 -3.52% ✓ $655.2K
Feb 10, 2023 Feb 14, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 23.8 -5,355 -7.96% ✓ $1.6M
Jan 31, 2023 Feb 2, 2023 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 52.5 -106 -0.28% ✓ $34.5K
Nov 1, 2022 Nov 3, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 38.8 -1,088 -2.78% ✓ $340.3K
Oct 18, 2022 Oct 20, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 35.0 -1,791 -4.37% ✓ $537.9K
Aug 1, 2022 Aug 3, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 22.5 -766 -1.83% ✗ $211.9K
May 16, 2022 May 18, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 53.8 -45 -0.11% ✓ $11.4K
May 4, 2022 May 6, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 56.3 -36 -0.09% ✓ $9.9K
May 2, 2022 May 4, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 47.5 -320 -0.76% ✓ $82.9K
Apr 29, 2022 May 3, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 22.5 -766 -1.79% ✗ $211.5K
Apr 7, 2022 Apr 8, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 45.0 -561 -1.29% ✓ $154.9K
Apr 4, 2022 Apr 6, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 23.8 -3,725 -7.91% ✓ $1M
Apr 1, 2022 Apr 5, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 20.0 -1,344 -2.78% ✗ $353.6K
Mar 17, 2022 Mar 21, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 35.0 -2,122 -4.20% ✓ $530.6K
Feb 17, 2022 Feb 22, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 20.0 -3,439 -6.37% ✗ $799.6K
Feb 10, 2022 Feb 14, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 22.5 -979 -1.78% ✗ $232.7K
Feb 1, 2022 Feb 3, 2022 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 97.5 +22,376 68.69% ✓ $389.2K
Nov 1, 2021 Nov 3, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 22.5 -766 -2.30% ✗ $141.8K
Jul 30, 2021 Aug 3, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 22.5 -766 -2.25% ✗ $153.5K
May 17, 2021 May 19, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 52.5 -112 -0.33% ✓ $24.2K
Apr 30, 2021 May 5, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 35.0 -1,726 -4.82% ✓ $376.1K
Apr 5, 2021 Apr 7, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 35.0 -1,686 -4.49% ✓ $361K
Apr 1, 2021 Apr 5, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 20.0 -1,344 -3.46% ✗ $287.8K
Feb 11, 2021 Feb 16, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 35.0 -1,686 -4.16% ✓ $355K
Feb 10, 2021 Feb 12, 2021 VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Sell 20.0 -1,344 -3.21% ✗ $287.8K